Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AFRICA: Atorvastatin Plus Fenofibric Acid in Coronary Atherosclerosis
NCT01030328Phase 3Withdrawn
- Sponsor
- Piedmont Healthcare
- Start
- Nov 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibric acid, atorvastatin in Coronary atherosclerosis (CAD), sponsored by Piedmont Healthcare. Planned start Nov 2009; status: withdrawn.
02
Drugs
fenofibric acidatorvastatin
03
Conditions
Coronary atherosclerosis (CAD)
Beyond the preview
Go deeper on NCT01030328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01030328.